- Home
- Publications
- Publication Search
- Publication Details
Title
BET Inhibition Improves NASH and Liver Fibrosis
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-16
DOI
10.1038/s41598-018-35653-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonalcoholic Steatohepatitis (NASH) and Hepatic Fibrosis: Emerging Therapies
- (2018) Julia Wattacheril et al. Annual Review of Pharmacology and Toxicology
- A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
- (2018) Scott L. Friedman et al. HEPATOLOGY
- Progress and challenges in the prevention and control of nonalcoholic fatty liver disease
- (2018) Jingjing Cai et al. MEDICINAL RESEARCH REVIEWS
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
- (2017) Zobair Younossi et al. Nature Reviews Gastroenterology & Hepatology
- BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1
- (2017) Simon J. Hogg et al. Cell Reports
- Clinical progress and pharmacology of small molecule bromodomain inhibitors
- (2016) Natalie H Theodoulou et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- C-X-C motif chemokine 10 in non-alcoholic steatohepatitis: role as a pro-inflammatory factor and clinical implication
- (2016) Zhilu Xu et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Effect of telmisartan on histological activity and fibrosis of non-alcoholic steatohepatitis: A 1-year randomized control trial
- (2016) Shahinul Alam et al. Saudi Journal of Gastroenterology
- Beating the odds: BETs in disease
- (2015) Chen-Yi Wang et al. TRENDS IN BIOCHEMICAL SCIENCES
- BET bromodomain inhibition suppresses transcriptional responses to cytokine-Jak-STAT signaling in a gene-specific manner in human monocytes
- (2014) Chun Hin Chan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis
- (2014) Xiang Zhang et al. JOURNAL OF HEPATOLOGY
- The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
- (2014) Junwei Shi et al. MOLECULAR CELL
- LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures
- (2014) Qiaonan Duan et al. NUCLEIC ACIDS RESEARCH
- Epigenetic modulation of type-1 diabetes via a dual effect on pancreatic macrophages and β cells
- (2014) Wenxian Fu et al. eLife
- Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994
- (2013) Mariana Lazo et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet
- (2013) Xiao-Yu Luo et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- BET Protein Function Is Required for Inflammation: Brd2 Genetic Disruption and BET Inhibitor JQ1 Impair Mouse Macrophage Inflammatory Responses
- (2013) A. C. Belkina et al. JOURNAL OF IMMUNOLOGY
- A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma
- (2013) Masato Fujii et al. Medical Molecular Morphology
- BRD4 Coordinates Recruitment of Pause Release Factor P-TEFb and the Pausing Complex NELF/DSIF To Regulate Transcription Elongation of Interferon-Stimulated Genes
- (2013) M. C. Patel et al. MOLECULAR AND CELLULAR BIOLOGY
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Milk thistle to treat non-alcoholic fatty liver disease: dream or reality?
- (2013) Ludovico Abenavoli et al. Expert Review of Gastroenterology & Hepatology
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)
- (2012) Jonathan Seal et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- (2012) Naga Chalasani et al. HEPATOLOGY
- Bromodomains as therapeutic targets
- (2011) Susanne Muller et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Nonalcoholic Steatohepatitis: A Review of the Literature and Updates in Management
- (2011) Lakshmi Pasumarthy et al. SOUTHERN MEDICAL JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started